Haleon (HLN) Asset Utilization Ratio (2023)

Haleon (HLN) posted Asset Utilization Ratio of 0.49 for Q4 2023.

Haleon (HLN) Asset Utilization Ratio (2023) Analysis & Trends

Haleon's Asset Utilization Ratio history runs 1 years deep, the most recent figure standing at 0.49 for Q4 2023.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.49 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.49 (changed N/A YoY) and the FY2025 annual result came in at 0.33, up 0.51% from the prior year.
Asset Utilization Ratio was 0.49 for Q4 2023 at Haleon.
Across five years, Asset Utilization Ratio topped out at 0.49 in Q4 2023 and bottomed at 0.49 in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Haleon	88.07 Bn	86.20 Bn	-	-
2	Teva Pharmaceutical Industries	35.75 Bn	32.01 Bn	1.97 Bn	0.43
3	Zoetis	31.84 Bn	29.90 Bn	1.62 Bn	0.62
4	Takeda Pharmaceutical	27.18 Bn	23.12 Bn	4.39 Bn	0.46
5	United Therapeutics	23.09 Bn	20.93 Bn	648.10 Mn	0.43
6	RedHill Biopharma	21.32 Bn	21.32 Bn	-	-
7	Viatris	19.96 Bn	18.16 Bn	1.16 Bn	0.39
8	Neurocrine Biosciences	17.66 Bn	16.34 Bn	800.70 Mn	0.65
9	Elanco Animal Health	12.44 Bn	12.02 Bn	785.00 Mn	0.37
10	Vireo Growth	10.53 Bn	10.38 Bn	59.30 Mn	0.40

Historic Data

Download Data

Date	Value
Dec 31, 2023	0.49